As the X-Men continue to mourn the loss of Krakoa, the Hellfire Vigil has given the team new looks with one member getting ...

Marvel has released a new Hellfire Gala that serves as an eulogy to one of the X-Men's greatest eras in comics.

In previous years, the Hellfire Gala comics typically kicked off a big X-Men event. The X-Men: Hellfire Vigil #1 special is ...

Major future Storm revelations in this week's X-Men: Hellfire Vigil #1 (XSpoilers... no seriously, Big spoilers) ...

Hellfire Vigil #1 on Wednesday, and you can get yourself a sneak peek with the official preview of the issue below… One year ...

One year after the Hellfire Gala disaster, X-Men: Hellfire Vigil #1 brings mutants together for solidarity and celebration ...

A phase 2 study of Vigil Neuroscience’s iluzanebart has missed its biomarker and efficacy endpoints, prompting the Sanofi-bound biotech to stop a long-term extension trial of the TREM2 agonist ...

The Hellfire missile is touted as being able to destroy any known tank in the world. It's a powerful missile that can be fired from the ground, sea, and air.

Marvel reveals a first look at X-Men: Hellfire Vigil #1, featuring a celebration of their time on Krakoa and of the Hellfire Gala.

Vigil Neuroscience shares jumped nearly 250% Thursday after the Alzheimer's disease drug developer reached a deal to be acquired by French pharmaceutical giant Sanofi.

Market analysts have called Vigil’s oral drug a "paradigm shifter" in Alzheimer’s disease treatment.

Sanofi has entered an agreement to acquire Vigil Neuroscience for approximately $470 million, adding a new investigational treatment for Alzheimer’s disease to the French pharmaceutical company ...